Wu X - Search Results

1

KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer.

Wu Y, Chen S, Shao Y, Su Y, Li Q, Wu J, Zhu J, Wen H, Huang Y, Zheng Z, Chen X, Ju X, Huang S, Wu X, Hu Z. Wu Y, et al. Among authors: wu x, wu j. Adv Sci (Weinh). 2023 Nov;10(31):e2304638. doi: 10.1002/advs.202304638. Epub 2023 Sep 13. Adv Sci (Weinh). 2023. PMID: 37702443 Free PMC article.

2

EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.

Ju XZ, Yang JM, Zhou XY, Li ZT, Wu XH. Ju XZ, et al. Clin Cancer Res. 2008 Jan 15;14(2):494-501. doi: 10.1158/1078-0432.CCR-07-1072. Clin Cancer Res. 2008. PMID: 18223224

3

[Nerve-sparing radical hysterectomy and radical hysterectomy: a retrospective study].

Ju XZ, Li ZT, Yang HJ, Wu XH. Ju XZ, et al. Zhonghua Fu Chan Ke Za Zhi. 2009 Aug;44(8):605-9. Zhonghua Fu Chan Ke Za Zhi. 2009. PMID: 20003790 Chinese.

4

Radical abdominal trachelectomy for cervical malignancies: surgical, oncological and fertility outcomes in 62 patients.

Li J, Li Z, Wang H, Zang R, Zhou Y, Ju X, Ke G, Wu X. Li J, et al. Among authors: wu x. Gynecol Oncol. 2011 Jun 1;121(3):565-70. doi: 10.1016/j.ygyno.2011.01.032. Epub 2011 Feb 21. Gynecol Oncol. 2011. PMID: 21334051

5

A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer.

Wen H, Wu X, Li Z, Wang H, Zang R, Sun M, Huang X, Zhang Z, Cai S. Wen H, et al. Among authors: wu x. Int J Gynecol Cancer. 2012 Feb;22(2):296-302. doi: 10.1097/IGC.0b013e31823610a1. Int J Gynecol Cancer. 2012. PMID: 22274319 Clinical Trial.

6

17β-Oestradiol activates proteolysis and increases invasion through phosphatidylinositol 3-kinase pathway in human cervical cancer cells.

Huang Y, Li J, Xiang L, Han D, Shen X, Wu X. Huang Y, et al. Among authors: wu x. Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):307-12. doi: 10.1016/j.ejogrb.2012.07.026. Epub 2012 Aug 28. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22938817

7

Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.

Shi TY, Cheng X, Yu KD, Sun MH, Shao ZM, Wang MY, Zhu ML, He J, Li QX, Chen XJ, Zhou XY, Wu X, Wei Q. Shi TY, et al. Among authors: wu x. Carcinogenesis. 2013 Apr;34(4):770-8. doi: 10.1093/carcin/bgt001. Epub 2013 Jan 8. Carcinogenesis. 2013. PMID: 23299407

8

Abdominal radical trachelectomy: Is it safe for IB1 cervical cancer with tumors ≥ 2 cm?

Li J, Wu X, Li X, Ju X. Li J, et al. Among authors: wu x. Gynecol Oncol. 2013 Oct;131(1):87-92. doi: 10.1016/j.ygyno.2013.07.079. Epub 2013 Jul 19. Gynecol Oncol. 2013. PMID: 23872192

9

Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer.

Liang S, Zhou Y, Chen Y, Ke G, Wen H, Wu X. Liang S, et al. Among authors: wu x. Int J Gynecol Cancer. 2014 Jun;24(5):908-15. doi: 10.1097/IGC.0000000000000152. Int J Gynecol Cancer. 2014. PMID: 24844222

10

Surgical and pathological outcomes of abdominal radical trachelectomy versus hysterectomy for early-stage cervical cancer.

Zhang D, Li J, Ge H, Ju X, Chen X, Tang J, Wu X. Zhang D, et al. Among authors: wu x. Int J Gynecol Cancer. 2014 Sep;24(7):1312-8. doi: 10.1097/IGC.0000000000000185. Int J Gynecol Cancer. 2014. PMID: 24987922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,174 results

Search Page

Filters